Detalus Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Detalus Advisors's LLY Position: Q2 2026 in Review
Detalus Advisors increased its Eli Lilly (LLY) stake by 3.3% in Q2 2026, buying an estimated $28.6K and bringing the position to 872 shares worth $1.05M. The position accounts for 0.2% of the portfolio, ranked #58.
Detalus Advisors first reported a position in LLY in Q4 2021 and has held it in 18 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Detalus Advisors held 872 shares of Eli Lilly worth $1.05M as of Q2 2026.
- Detalus Advisors bought 28 Eli Lilly shares in Q2 2026, an estimated $28.6K.
- Eli Lilly made up 0.2% of Detalus Advisors's portfolio in Q2 2026, its #58 holding.
- Detalus Advisors first reported a position in Eli Lilly in Q4 2021 and has held it in 18 quarters since.
- 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Detalus Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.